Home › Funds › ACT CAPITAL MANAGEMENT, LLC › CRVS
ACT CAPITAL MANAGEMENT, LLC position in CRVS
CORVUS PHARMACEUTICALS I · Health Care
ACT CAPITAL MANAGEMENT, LLC reported holding 27,000 shares of CRVS (CORVUS PHARMACEUTICALS I) in its Q2 2026 13F filing — a position valued at US$403K, representing 0.26% of its reported portfolio and ranking #43 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACT CAPITAL MANAGEMENT, LLC's CRVS position evolved
ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in CRVS in Q2 2026 at 27,000 shares (US$403K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 27.00K | $403.38K | New |
About CRVS and 13F data
CRVS (CORVUS PHARMACEUTICALS I) is a Health Care company. 73 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), Vivo Capital, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRVS
- ORBIMED ADVISORS LLC 7.17M sh · $107.05M · Q2 2026
- ADAMS STREET PARTNERS LLC 3.28M sh · $48.94M · Q2 2026
- Vivo Capital, LLC 2.81M sh · $41.92M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.67M sh · $39.85M · Q2 2026
- Deep Track Capital, LP 2.49M sh · $37.23M · Q2 2026
- BRAIDWELL LP 2.13M sh · $31.77M · Q2 2026
- Foresite Capital Management VI LLC 1.83M sh · $27.36M · Q2 2026
- Boxer Capital Management, LLC 1.10M sh · $16.43M · Q2 2026
- Catalio Capital Management, LP 1.08M sh · $16.15M · Q2 2026
- Eversept Partners, LP 747.99K sh · $11.18M · Q2 2026
- DCF Advisers, LLC 637.50K sh · $9.52M · Q2 2026
- Blue Owl Capital Holdings LP 608.60K sh · $9.09M · Q2 2026
More on ACT CAPITAL MANAGEMENT, LLC
FAQ
How long has ACT CAPITAL MANAGEMENT, LLC held CRVS?
ACT CAPITAL MANAGEMENT, LLC has disclosed CRVS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is ACT CAPITAL MANAGEMENT, LLC's current position in CRVS?
As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 27.00K shares of CRVS (CORVUS PHARMACEUTICALS I), valued at $403.38K, representing 0.26% of its reported portfolio and ranking #43.
Has ACT CAPITAL MANAGEMENT, LLC been buying or selling CRVS?
In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC newly opened its position in CRVS.
Which other funds hold CRVS?
Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Vivo Capital, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.